Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Nachman

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
AIDS Research and Human Retroviruses|April 18, 2002
Mother-to-child transmission in the United States of subtypes D and A/G human immunodeficiency virus type 1Paul Krogstad, Susan H Eshleman, Yongzhi Geng, et al.
Vaccine|April 19, 2011
Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancerNatasha Halasa, Janet A Englund, Sharon Nachman, et al.
Pediatrics|February 3, 2005
Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected childrenRita J Jeremy, Soyeon Kim, Molly Nozyce, et al.
Pediatrics|March 18, 2005
The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxisSharon Nachman, Philimon Gona, Wayne Dankner, et al.
BMC Health Services Research|May 27, 2020
Provider attitudes about childhood tuberculosis prevention in Lesotho: a qualitative studyYael Hirsch-Moverman, Joanne E Mantell, Limakatso Lebelo, et al.
The Journal of Infectious Diseases|June 30, 2010
Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infantsShabir A Madhi, Peter Adrian, Mark F Cotton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 6, 2009
CYP2C19 genetic variants affect nelfinavir pharmacokinetics and virologic response in HIV-1-infected children receiving highly active antiretroviral therapyAkihiko Saitoh, Edmund Capparelli, Francesca Aweeka, et al.
Trials|November 22, 2017
The PREVENT study to evaluate the effectiveness and acceptability of a community-based intervention to prevent childhood tuberculosis in Lesotho: study protocol for a cluster randomized controlled trialYael Hirsch-Moverman, Andrea A Howard, Koen Frederix, et al.
Vaccine|July 4, 2008
Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected childrenMyron J Levin, Lin-Ye Song, Terrence Fenton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2020
Coronavirus Disease 2019 (COVID-19) Pharmacologic Treatments for Children: Research Priorities and Approach to Pediatric StudiesAnthony J Garcia-Prats, Nicole Salazar-Austin, James H Conway, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
AIDS Research and Human Retroviruses|April 18, 2002
Mother-to-child transmission in the United States of subtypes D and A/G human immunodeficiency virus type 1Paul Krogstad, Susan H Eshleman, Yongzhi Geng, et al.
Vaccine|April 19, 2011
Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancerNatasha Halasa, Janet A Englund, Sharon Nachman, et al.
Pediatrics|February 3, 2005
Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected childrenRita J Jeremy, Soyeon Kim, Molly Nozyce, et al.
Pediatrics|March 18, 2005
The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxisSharon Nachman, Philimon Gona, Wayne Dankner, et al.
BMC Health Services Research|May 27, 2020
Provider attitudes about childhood tuberculosis prevention in Lesotho: a qualitative studyYael Hirsch-Moverman, Joanne E Mantell, Limakatso Lebelo, et al.
The Journal of Infectious Diseases|June 30, 2010
Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infantsShabir A Madhi, Peter Adrian, Mark F Cotton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 6, 2009
CYP2C19 genetic variants affect nelfinavir pharmacokinetics and virologic response in HIV-1-infected children receiving highly active antiretroviral therapyAkihiko Saitoh, Edmund Capparelli, Francesca Aweeka, et al.
Trials|November 22, 2017
The PREVENT study to evaluate the effectiveness and acceptability of a community-based intervention to prevent childhood tuberculosis in Lesotho: study protocol for a cluster randomized controlled trialYael Hirsch-Moverman, Andrea A Howard, Koen Frederix, et al.
Vaccine|July 4, 2008
Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected childrenMyron J Levin, Lin-Ye Song, Terrence Fenton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2020
Coronavirus Disease 2019 (COVID-19) Pharmacologic Treatments for Children: Research Priorities and Approach to Pediatric StudiesAnthony J Garcia-Prats, Nicole Salazar-Austin, James H Conway, et al.
Pageof 11